Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Dabigatran etexilate

Aliases
Dabigatran etexilate + BI 1323495, Pradaxa
Name
Dabigatran Etexilate
INN Name
DABIGATRAN ETEXILATE
FDA Approved
Yes

8 clinical trials

9 organizations

11 indications

3 documents

Indication
Healthy
Indication
Advanced Non-small Cell Lung Cancer
Indication
EGFR mutation
Indication
HER2 Mutation
Indication
Healthy Control Participants
Indication
Vasomotor Symptoms
Indication
Hot Flashes
Indication
Atrial Fibrillation
Indication
Mitral Valve Stenosis
Indication
health
Indication
Subjective
Clinical trial
Relative Bioavailability of Rosuvastatin (Part 1) and Dabigatran (Part 2) Given Alone and Together With BI 1323495 in Healthy Male Subjects (Open, Single-dose, Randomised, Two-period Crossover Design in Each Trial Part)
Status: Completed, Estimated PCD: 2020-09-23
Clinical trial
A Phase 1, Open Label, Fixed Sequence, Crossover Study to Investigate the Effect of BAY 2927088 on the Pharmacokinetics of Dabigatran Etexilate or Rosuvastatin in Healthy Participants
Status: Recruiting, Estimated PCD: 2024-05-23
Clinical trial
Open-label, Fixed Sequence Crossover Study to Determine the Effects of a Single Dose of Elinzanetant (BAY 3427080) on the Pharmacokinetics of Dabigatran Etexilate in Healthy Participants
Status: Completed, Estimated PCD: 2022-09-20
Clinical trial
AN INTERVENTIONAL, PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, 2-PERIOD STUDY TO EVALUATE THE EFFECT OF A SINGLE ORAL DOSE OF ARV-471 (PF-07850327) ON THE PHARMACOKINETICS OF DABIGATRAN IN HEALTHY PARTICIPANTS
Status: Completed, Estimated PCD: 2023-04-19
Clinical trial
A Single-center, Open-label, Three-period, Fixed-sequence Design Study to Investigate the Effect of Daridorexant on the Pharmacokinetics of Dabigatran and Rosuvastatin in Healthy Male Subjects
Status: Completed, Estimated PCD: 2022-09-17
Clinical trial
A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE STUDY TO ESTIMATE THE EFFECT OF PF-07081532 ADMINISTRATION ON THE SINGLE-DOSE PHARMACOKINETICS OF DABIGATRAN AND ROSUVASTATIN IN OVERWEIGHT OR OBESE ADULT PARTICIPANTS
Status: Terminated, Estimated PCD: 2023-09-11
Clinical trial
Rationale and Design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial
Status: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
A Study Evaluating the Pharmacokinetics of Dabigatran Etexilate in Adult Healthy Subjects, Elderly Healthy Subjects, and Elderly Patients With Atrial Fibrillation
Status: Recruiting, Estimated PCD: 2023-06-30
Document
DailyMed Label: Dabigatran Etexilate
Organization
Ascend Laboratories, LLC
Organization
American Health Packaging
Organization
Alembic Pharmaceuticals Inc.
Organization
Camber Pharmaceuticals, Inc.
Document
DailyMed Label: Dabigatran Etexilate
Organization
XLCare Pharmaceuticals, Inc.
Document
DailyMed Label: Pradaxa
Organization
Boehringer Ingelheim Pharmaceuticals, Inc.
Organization
Alembic Pharmaceuticals Limited
Organization
Apotex Corp.
Organization
Novadoz Pharmaceuticals LLC